BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 28076790)

  • 1. The Anti-Warburg Effect Elicited by the cAMP-PGC1α Pathway Drives Differentiation of Glioblastoma Cells into Astrocytes.
    Xing F; Luan Y; Cai J; Wu S; Mai J; Gu J; Zhang H; Li K; Lin Y; Xiao X; Liang J; Li Y; Chen W; Tan Y; Sheng L; Lu B; Lu W; Gao M; Qiu P; Su X; Yin W; Hu J; Chen Z; Sai K; Wang J; Chen F; Chen Y; Zhu S; Liu D; Cheng S; Xie Z; Zhu W; Yan G
    Cell Rep; 2017 Jan; 18(2):468-481. PubMed ID: 28076790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MET Inhibition Elicits PGC1α-Dependent Metabolic Reprogramming in Glioblastoma.
    Zhang Y; Nguyen TTT; Shang E; Mela A; Humala N; Mahajan A; Zhao J; Shu C; Torrini C; Sanchez-Quintero MJ; Kleiner G; Bianchetti E; Westhoff MA; Quinzii CM; Karpel-Massler G; Bruce JN; Canoll P; Siegelin MD
    Cancer Res; 2020 Jan; 80(1):30-43. PubMed ID: 31694905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-capacity glycolytic and mitochondrial oxidative metabolisms mediate the growth ability of glioblastoma.
    Kim J; Han J; Jang Y; Kim SJ; Lee MJ; Ryu MJ; Kweon GR; Heo JY
    Int J Oncol; 2015 Sep; 47(3):1009-16. PubMed ID: 26202438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aurora kinase A inhibition reverses the Warburg effect and elicits unique metabolic vulnerabilities in glioblastoma.
    Nguyen TTT; Shang E; Shu C; Kim S; Mela A; Humala N; Mahajan A; Yang HW; Akman HO; Quinzii CM; Zhang G; Westhoff MA; Karpel-Massler G; Bruce JN; Canoll P; Siegelin MD
    Nat Commun; 2021 Sep; 12(1):5203. PubMed ID: 34471141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative regulation of miR-1275 by H3K27me3 is critical for glial induction of glioblastoma cells.
    Mai J; Gu J; Liu Y; Liu X; Sai K; Chen Z; Lu W; Yang X; Wang J; Guo C; Sun S; Xing F; Sheng L; Lu B; Zhu Z; Sun H; Xue D; Lin Y; Cai J; Tan Y; Li C; Yin W; Cao L; Ou-Yang Y; Qiu P; Su X; Yan G; Liang J; Zhu W
    Mol Oncol; 2019 Jul; 13(7):1589-1604. PubMed ID: 31162799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A metabolic function of FGFR3-TACC3 gene fusions in cancer.
    Frattini V; Pagnotta SM; Tala ; Fan JJ; Russo MV; Lee SB; Garofano L; Zhang J; Shi P; Lewis G; Sanson H; Frederick V; Castano AM; Cerulo L; Rolland DCM; Mall R; Mokhtari K; Elenitoba-Johnson KSJ; Sanson M; Huang X; Ceccarelli M; Lasorella A; Iavarone A
    Nature; 2018 Jan; 553(7687):222-227. PubMed ID: 29323298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth arrest and forced differentiation of human primary glioblastoma multiforme by a novel small molecule.
    Kang TW; Choi SW; Yang SR; Shin TH; Kim HS; Yu KR; Hong IS; Ro S; Cho JM; Kang KS
    Sci Rep; 2014 Jul; 4():5546. PubMed ID: 24989033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The angiogenic switch leads to a metabolic shift in human glioblastoma.
    Talasila KM; Røsland GV; Hagland HR; Eskilsson E; Flønes IH; Fritah S; Azuaje F; Atai N; Harter PN; Mittelbronn M; Andersen M; Joseph JV; Hossain JA; Vallar L; Noorden CJ; Niclou SP; Thorsen F; Tronstad KJ; Tzoulis C; Bjerkvig R; Miletic H
    Neuro Oncol; 2017 Mar; 19(3):383-393. PubMed ID: 27591677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC inhibitors elicit metabolic reprogramming by targeting super-enhancers in glioblastoma models.
    Nguyen TTT; Zhang Y; Shang E; Shu C; Torrini C; Zhao J; Bianchetti E; Mela A; Humala N; Mahajan A; Harmanci AO; Lei Z; Maienschein-Cline M; Quinzii CM; Westhoff MA; Karpel-Massler G; Bruce JN; Canoll P; Siegelin MD
    J Clin Invest; 2020 Jul; 130(7):3699-3716. PubMed ID: 32315286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atracurium Besylate and other neuromuscular blocking agents promote astroglial differentiation and deplete glioblastoma stem cells.
    Spina R; Voss DM; Asnaghi L; Sloan A; Bar EE
    Oncotarget; 2016 Jan; 7(1):459-72. PubMed ID: 26575950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YAP1-TEAD1 signaling controls angiogenesis and mitochondrial biogenesis through PGC1α.
    Mammoto A; Muyleart M; Kadlec A; Gutterman D; Mammoto T
    Microvasc Res; 2018 Sep; 119():73-83. PubMed ID: 29680477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of type I interferon on glioblastoma cancer stem cells.
    Du Z; Cai C; Sims M; Boop FA; Davidoff AM; Pfeffer LM
    Biochem Biophys Res Commun; 2017 Sep; 491(2):343-348. PubMed ID: 28728846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Transcription Factor 7-Like 2-Peroxisome Proliferator-Activated Receptor Gamma Coactivator-1 Alpha Axis Connects Mitochondrial Biogenesis and Metabolic Shift with Stem Cell Commitment to Hepatic Differentiation.
    Wanet A; Caruso M; Domelevo Entfellner JB; Najar M; Fattaccioli A; Demazy C; Evraerts J; El-Kehdy H; Pourcher G; Sokal E; Arnould T; Tiffin N; Najimi M; Renard P
    Stem Cells; 2017 Oct; 35(10):2184-2197. PubMed ID: 28795454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in Glioblastoma.
    Ishida CT; Zhang Y; Bianchetti E; Shu C; Nguyen TTT; Kleiner G; Sanchez-Quintero MJ; Quinzii CM; Westhoff MA; Karpel-Massler G; Prabhu VV; Allen JE; Siegelin MD
    Clin Cancer Res; 2018 Nov; 24(21):5392-5406. PubMed ID: 30037819
    [No Abstract]   [Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-γ (PPARγ) agonist is neuroprotective and stimulates PGC-1α expression and CREB phosphorylation in human dopaminergic neurons.
    Mäkelä J; Tselykh TV; Kukkonen JP; Eriksson O; Korhonen LT; Lindholm D
    Neuropharmacology; 2016 Mar; 102():266-75. PubMed ID: 26631533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined inhibition of glycolysis and AMPK induces synergistic breast cancer cell killing.
    Wu Y; Sarkissyan M; Mcghee E; Lee S; Vadgama JV
    Breast Cancer Res Treat; 2015 Jun; 151(3):529-39. PubMed ID: 25975952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic nucleotide phosphodiesterase-1C (PDE1C) drives cell proliferation, migration and invasion in glioblastoma multiforme cells in vitro.
    Rowther FB; Wei W; Dawson TP; Ashton K; Singh A; Madiesse-Timchou MP; Thomas DG; Darling JL; Warr T
    Mol Carcinog; 2016 Mar; 55(3):268-79. PubMed ID: 25620587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A PGC1α-mediated transcriptional axis suppresses melanoma metastasis.
    Luo C; Lim JH; Lee Y; Granter SR; Thomas A; Vazquez F; Widlund HR; Puigserver P
    Nature; 2016 Sep; 537(7620):422-426. PubMed ID: 27580028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions.
    Agnihotri S; Zadeh G
    Neuro Oncol; 2016 Feb; 18(2):160-72. PubMed ID: 26180081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MOB2 suppresses GBM cell migration and invasion via regulation of FAK/Akt and cAMP/PKA signaling.
    Jiang K; Yao G; Hu L; Yan Y; Liu J; Shi J; Chang Y; Zhang Y; Liang D; Shen D; Zhang G; Meng S; Piao H
    Cell Death Dis; 2020 Apr; 11(4):230. PubMed ID: 32286266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.